Administrative Core
Administrative Core
批准号:
10714389
负责人:
JAN VIJG
金额:
$22.35万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-15 至 2028-08-31
关键词:
AffectAgingBiological AssayBiology of AgingCell AgingCellsCentenarianChairpersonCohort StudiesCommunicationCommunitiesDNA RepairDataData SetDatabasesDiseaseDrug ScreeningDrug TargetingElderlyEnsureFundingGenesGeneticGenetic ScreeningGenomeGenomicsGerman populationGoalsGrantHealthHumanHuman GeneticsHuman ResourcesInstitutionInterventionLeadershipLocationLongevityMedicineMetabolismMinnesotaMonitorNew EnglandNew YorkPathway interactionsPhenotypeQualifyingReagentRegulationReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesScientific EvaluationTechnologyTestingTissue SampleUnited States National Institutes of HealthUniversitiesValidationVariantage relatedcohortcollegedata integrationdata resourcedata sharingdrug developmentdrug discoveryexomeexome sequencinggenetic analysisgenetic informationgenetic resourcegenetic variantgenomic datahealthspanhealthy aginghigh throughput screeninginduced pluripotent stem cellinterdisciplinary approachmouse geneticsmouse modelnew technologynovelprogramspromote resiliencerecruitscreeningsmall moleculesoundstem cell biologytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Core A, the Administrative Core, will serve the proposed U19 project “Genetic variant-based drug discovery
targeting conserved pathways of aging”, comprised of four projects and one research resource Core (Core B).
The PIs are Dr. Jan Vijg, Chairman of the Department of Genetics at the Albert Einstein College of Medicine, an
expert in aging and DNA damage repair, Dr. Paul Robbins, Co-Director of the Institute on the Biology of Aging
and Metabolism (iBAM) at the University of Minnesota, an expert in cellular senescence and drug development,
and Dr. Nir Barzilai, Director of the Institute for Aging Research at the Albert Einstein College of Medicine, a
geroscientist recruiting and phenotyping aging humans and expert in the genetics of exceptional longevity. These
complementary and synergistic qualifications make Drs. Vijg, Robbins and Barzilai well-qualified to co-direct this
U19. Having established the feasibility of using the genetics of human centenarians to identify genes and
pathways as candidates for potential drug targets for promoting human healthspan, the focus of the renewal
application will be to expand the program through whole exome analysis of our own and other, additional genetic
resources, further gene functionalization, developing additional mouse models and expanding our pipeline of
candidate interventions. To accomplish these goals, we propose an interdisciplinary approach, making full use
of the latest advances in cellular genomics, high-throughput functional screening, stem cell biology, mouse and
human genetics and drug screening. The overall goals of the Administrative Core will be to ensure this approach
is working effectively by providing general scientific, programmatic and fiscal leadership, facilitate lines of
communication between the different researchers involved in the U19, maintain coherence in the U19's overall
and long-range goals, and ensure that resources resulting from the research will benefit the scientific community.
In the context of the above, the tasks of this Core include effective coordination of activities by the four Research
Projects and the one Research Resource Core (Core B). This should promote and expand the effective use of
the human centenarian cohorts to obtain genetic information critical for developing targets for drugs promoting
human healthspan, for example, by increasing resilience, the mobilization of new technology and tools that can
help us accomplish our tasks more quickly and efficiently and providing access by the scientific community to
the resources, information and technologies produced.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ConProject-001
-
批准号:10600806
-
项目类别:
-
资助金额:$2.37万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Development of novel therapeutics targeting the identified pathways associated with human longevity
-
批准号:10714394
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-003
-
批准号:10653286
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-005
-
批准号:10653292
-
项目类别:
-
资助金额:$10.86万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-006
-
批准号:10653296
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Genetic variant-based drug discovery targeting conserved pathways of aging
-
批准号:9916672
-
项目类别:
-
资助金额:$187.65万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Genetic variant-based drug discovery targeting conserved pathways of aging
-
批准号:9359668
-
项目类别:
-
资助金额:$191.07万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Validation and characterization of the identified variants associated with human longevity in mouse models
-
批准号:10714393
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-002
-
批准号:10600807
-
项目类别:
-
资助金额:$9.48万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Admin-Core-001
-
批准号:10600778
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Identification and characterization of functional genetic variants associated with human longevity
-
批准号:10714392
-
项目类别:
-
资助金额:$61.32万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-001
-
批准号:10765766
-
项目类别:
-
资助金额:$14.35万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-004
-
批准号:10653290
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Bridge Funding - Genetic variant-based drug discovery targeting conserved pathways of aging
-
批准号:10733650
-
项目类别:
-
资助金额:$44.41万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-002
-
批准号:10765767
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
ConProject-003
-
批准号:10765768
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2017
-
负责人:JAN VIJG
-
依托单位:
Somatic mutation and epimutation rate and species-specific longevity
-
批准号:10399523
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2014
-
负责人:JAN VIJG
-
依托单位:
Somatic mutation and epimutation rate and species-specific longevity
-
批准号:10620753
-
项目类别:
-
资助金额:$33.7万
-
财政年份:2014
-
负责人:JAN VIJG
-
依托单位:
Somatic mutation and epimutation rate and species-specific longevity
-
批准号:10152479
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2014
-
负责人:JAN VIJG
-
依托单位:
Direct Somatic Mutation Analysis Through Sequencing
-
批准号:8013181
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2011
-
负责人:JAN VIJG
-
依托单位:
海外基金